Module

Update on Mantle Cell Lymphoma and Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

Source: Lymphoma Annual Update 2005

Update on Mantle Cell Lymphoma and Diffuse Large B-Cell Non-Hodgkin’s Lymphoma


Program Director: Julie M. Vose, MD

Faculty:

  • Richard I. Fisher, MD
  • Jonathan W. Friedberg, MD

CME CREDIT INFORMATION

Release Date: 08/19/05

Expiration Date: 08/18/06


Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review current therapeutic strategies for the treatment of mantle cell lymphoma.

  • Evaluate the use of rituximab in the treatment of diffuse large B-cell lymphoma.

  • Discuss novel treatments currently being evaluated in clinical trials for patients with diffuse large B-cell lymphoma and mantle cell lymphoma.


Content includes:

  • Rituximab for Mantle Cell Lymphoma
  • HyperCVAD or ASCT After Standard Therapy for MCL
  • Novel Approaches for the Treatment of MCL
  • Diffuse Large B-Cell Lymphoma - Clinical Risk Stratification
  • Rituximab for Diffuse Large B-Cell Lymphoma
  • Rituximab and Dose-Intense Regimens for DLBCL
  • Consolidative Autologous Stem Cell Transplant for DLBCL
  • Radioimmunotherapy in DLBCL
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.